Combined diet and exercise allocations
Source-reported context, pending human review. Membership uses registered source-bound placement rules, not equivalent clinical outcomes, personal suitability or a treatment recommendation.
Research question: What did the authors report in this source context, with their stated populations, comparisons and measurement windows?
Agreement, disagreement and a clinical recommendation are not established by these records. Different populations, interventions, routes, instruments and timepoints remain separate; no pooling is performed.
This filtered view rechecked source-context candidates for current publication and source integrity. Other papers were not evaluated; an empty result does not establish that research is absent. Browse the broader bounded research library.
Bounded to up to200 processed papers. Checked .
All topics · All public findings
- PMID 39427878: read the complete source record
allocated intervention context. AI-extracted — pending human review. Not poolable. Finding version2; paper version3.
Authors’ record type: study_comparisons. 10 matching comparison records, retaining nulls and uncertainty.
Authors-reported study comparisons and phases; no platform pooling.; Secondary analysis of a four-arm randomized trial.; Adjustment and analysis population are not established by this extraction.; Allocation counts are not analyzed sample sizes.; Authors-reported contrasts; no platform synthesis or component-level attribution.; Study population: persons living with type 2 diabetes.; Authors report no differences in the remaining VAT comparisons; named contrast mapping is not extracted, and no equivalence is inferred.; Authors report fat-free mass decrease in DCON and MED and preservation in HED, with an HED reported estimate of -0.2% (95% CI -2% to 1.7%). Its exact estimand and comparison are not encoded as a numeric contrast and require review.; Secondary analysis of a four-arm randomized trial.; Adjustment and analysis population are not established by this extraction.; Allocation counts are not analyzed sample sizes.; Authors-reported contrasts; no platform synthesis or component-level attribution.; Study population: persons living with type 2 diabetes.; Authors report no differences in the remaining VAT comparisons; named contrast mapping is not extracted, and no equivalence is inferred.; Authors report fat-free mass decrease in DCON and MED and preservation in HED, with an HED reported estimate of -0.2% (95% CI -2% to 1.7%). Its exact estimand and comparison are not encoded as a numeric contrast and require review.; Secondary analysis of a four-arm randomized trial.; Adjustment and analysis population are not established by this extraction.; Allocation counts are not analyzed sample sizes.; Authors-reported contrasts; no platform synthesis or component-level attribution.; Study population: persons living with type 2 diabetes.; Authors report no differences in the remaining VAT comparisons; named contrast mapping is not extracted, and no equivalence is inferred.; Authors report fat-free mass decrease in DCON and MED and preservation in HED, with an HED reported estimate of -0.2% (95% CI -2% to 1.7%). Its exact estimand and comparison are not encoded as a numeric contrast and require review.; Secondary analysis of a four-arm randomized trial.; Adjustment and analysis population are not established by this extraction.; Allocation counts are not analyzed sample sizes.; Authors-reported contrasts; no platform synthesis or component-level attribution.; Study population: persons living with type 2 diabetes.; Authors report no differences in the remaining VAT comparisons; named contrast mapping is not extracted, and no equivalence is inferred.; Authors report fat-free mass decrease in DCON and MED and preservation in HED, with an HED reported estimate of -0.2% (95% CI -2% to 1.7%). Its exact estimand and comparison are not encoded as a numeric contrast and require review.; Secondary analysis of a four-arm randomized trial.; Adjustment and analysis population are not established by this extraction.; Allocation counts are not analyzed sample sizes.; Authors-reported contrasts; no platform synthesis or component-level attribution.; Study population: persons living with type 2 diabetes.; Authors report no differences in the remaining VAT comparisons; named contrast mapping is not extracted, and no equivalence is inferred.; Authors report fat-free mass decrease in DCON and MED and preservation in HED, with an HED reported estimate of -0.2% (95% CI -2% to 1.7%). Its exact estimand and comparison are not encoded as a numeric contrast and require review.; Secondary analysis of a four-arm randomized trial.; Adjustment and analysis population are not established by this extraction.; Allocation counts are not analyzed sample sizes.; Authors-reported contrasts; no platform synthesis or component-level attribution.; Study population: persons living with type 2 diabetes.; Authors report no differences in the remaining VAT comparisons; named contrast mapping is not extracted, and no equivalence is inferred.; Authors report fat-free mass decrease in DCON and MED and preservation in HED, with an HED reported estimate of -0.2% (95% CI -2% to 1.7%). Its exact estimand and comparison are not encoded as a numeric contrast and require review.; Secondary analysis of a four-arm randomized trial.; Adjustment and analysis population are not established by this extraction.; Allocation counts are not analyzed sample sizes.; Authors-reported contrasts; no platform synthesis or component-level attribution.; Only independently source-stated VAT numeric contrasts are represented.; Study population: persons living with type 2 diabetes.; Authors report no differences in the remaining VAT comparisons; named contrast mapping is not extracted, and no equivalence is inferred.; Authors report fat-free mass decrease in DCON and MED and preservation in HED, with an HED reported estimate of -0.2% (95% CI -2% to 1.7%). Its exact estimand and comparison are not encoded as a numeric contrast and require review.; Secondary analysis of a four-arm randomized trial.; Adjustment and analysis population are not established by this extraction.; Allocation counts are not analyzed sample sizes.; Authors-reported contrasts; no platform synthesis or component-level attribution.; Only independently source-stated VAT numeric contrasts are represented.; Study population: persons living with type 2 diabetes.; Authors report no differences in the remaining VAT comparisons; named contrast mapping is not extracted, and no equivalence is inferred.; Authors report fat-free mass decrease in DCON and MED and preservation in HED, with an HED reported estimate of -0.2% (95% CI -2% to 1.7%). Its exact estimand and comparison are not encoded as a numeric contrast and require review.; Secondary analysis of a four-arm randomized trial.; Adjustment and analysis population are not established by this extraction.; Allocation counts are not analyzed sample sizes.; Authors-reported contrasts; no platform synthesis or component-level attribution.; Only independently source-stated VAT numeric contrasts are represented.; Study population: persons living with type 2 diabetes.; Authors report no differences in the remaining VAT comparisons; named contrast mapping is not extracted, and no equivalence is inferred.; Authors report fat-free mass decrease in DCON and MED and preservation in HED, with an HED reported estimate of -0.2% (95% CI -2% to 1.7%). Its exact estimand and comparison are not encoded as a numeric contrast and require review.; Secondary analysis of a four-arm randomized trial.; Adjustment and analysis population are not established by this extraction.; Allocation counts are not analyzed sample sizes.; Authors-reported contrasts; no platform synthesis or component-level attribution.; Only independently source-stated VAT numeric contrasts are represented.; Study population: persons living with type 2 diabetes.; Authors report no differences in the remaining VAT comparisons; named contrast mapping is not extracted, and no equivalence is inferred.; Authors report fat-free mass decrease in DCON and MED and preservation in HED, with an HED reported estimate of -0.2% (95% CI -2% to 1.7%). Its exact estimand and comparison are not encoded as a numeric contrast and require review.